Business Information
The group's principal activities are the development, production, marketing and distribution of two types of products: pharmaceuticals - development, manufacturing and selling of medicines in various dosages and forms, disposable of hospital products and equipment for hospital use and veterinary products, and active pharmaceutical ingredients (api) - development, manufacturing and selling of api for the pharmaceutical industry, including the group's pharmaceutical segment.
|
|
Name |
Title
|
Email
|
| Eli Hurvitz | Chmn. | N/A | | Phillip Frost | Vice Chmn. | N/A | | Shlomo Yanai | CEO, Pres. | N/A | | William Marth | CEO, Pres. - Teva Pharmaceuticals Usa, Inc | N/A | | Dan Suesskind | CFO | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 8,408,000 | 546,000 | | 2005 | 5,250,400 | 1,072,300 | | 2004 | 4,798,900 | 331,800
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
